EXCLUSIVE LICENSE AGREEMENT BETWEEN THE UNIVERSITY OF CHICAGO AND PYXIS ONCOLOGY FOR CANCER IMMUNOTHERAPY TECHNOLOGY

AutoNDA by SimpleDocs
Time is Money Join Law Insider Premium to draft better contracts faster.